cbdMD (YCBD) Common Equity (2016 - 2026)
cbdMD (YCBD) posted Common Equity of $9.0 million for Q4 2025, up 24.66% sequentially from $7.2 million in Q3 2025, and up 405.61% YoY from $1.8 million in Q4 2024.
cbdMD (YCBD) Common Equity (2016 - 2026) Analysis & Trends
cbdMD has reported Common Equity for 10 years, with the latest figure at $9.0 million in Q4 2025.
- Quarterly Common Equity rose 405.61% year-over-year to $9.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.0 million (up 405.61% YoY) and the FY2025 annual result came in at $7.2 million, up 268.04% from the prior year.
- Common Equity improved to $9.0 million in Q4 2025 per YCBD's latest filing, from $7.2 million in the prior quarter.
- Over five years, Common Equity peaked at $103.1 million in Q3 2021 and troughed at $665798.0 in Q1 2025.
- A 5-year average of $32.4 million and a median of $9.0 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity slumped 88.23% in 2024, then jumped 405.61% in 2025.
- Over 5 years, Common Equity stood at $84.4 million in 2021, then plunged by 68.49% to $26.6 million in 2022, then sank by 73.54% to $7.0 million in 2023, then sank by 74.68% to $1.8 million in 2024, then surged by 405.61% to $9.0 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $9.0 million, $7.2 million, and $6.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 4.05 Bn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 8.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.21 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Sep 30, 2025 | 7.23 Mn |
| Jun 30, 2025 | 6.11 Mn |
| Mar 31, 2025 | 665,798.00 |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Sep 30, 2023 | 9.03 Mn |
| Jun 30, 2023 | 25.73 Mn |
| Mar 31, 2023 | 25.79 Mn |
| Dec 31, 2022 | 26.59 Mn |
| Jun 30, 2022 | 46.60 Mn |
| Mar 31, 2022 | 80.02 Mn |
| Dec 31, 2021 | 84.40 Mn |
| Sep 30, 2021 | 103.14 Mn |
| Jun 30, 2021 | 89.28 Mn |
| Mar 31, 2021 | 85.88 Mn |